

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.93897952 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.93897952 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.93897952 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.93897952 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.93897952 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.93897952 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.93402696 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.93402696 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.70922981 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 5.66707426 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.64148478 |
| 12 | response to peptidoglycan (GO:0032494) | 5.56299620 |
| 13 | detection of other organism (GO:0098543) | 5.36200912 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 5.16925659 |
| 15 | detection of bacterium (GO:0016045) | 5.11049195 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 4.99839752 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.90708342 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.84909962 |
| 19 | cellular extravasation (GO:0045123) | 4.78556500 |
| 20 | leukocyte aggregation (GO:0070486) | 4.55682498 |
| 21 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.54550463 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.52173595 |
| 23 | neutrophil activation (GO:0042119) | 4.49984232 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.47394585 |
| 25 | detection of molecule of bacterial origin (GO:0032490) | 4.45149396 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 4.38660077 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.38133631 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.32304660 |
| 29 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.18451408 |
| 30 | respiratory burst (GO:0045730) | 4.17611809 |
| 31 | granulocyte activation (GO:0036230) | 4.15126523 |
| 32 | response to host immune response (GO:0052572) | 4.14119146 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.14119146 |
| 34 | microglial cell activation (GO:0001774) | 4.12338277 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 4.07722775 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.07044134 |
| 37 | detection of biotic stimulus (GO:0009595) | 4.06353892 |
| 38 | regulation of mast cell degranulation (GO:0043304) | 3.99716597 |
| 39 | positive regulation of mast cell activation (GO:0033005) | 3.90171971 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.85338752 |
| 41 | macrophage activation (GO:0042116) | 3.83685472 |
| 42 | neutrophil mediated immunity (GO:0002446) | 3.82047392 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.82045333 |
| 44 | response to host defenses (GO:0052200) | 3.74623736 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.74623736 |
| 46 | response to host (GO:0075136) | 3.74623736 |
| 47 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.71187522 |
| 48 | negative regulation of T cell mediated immunity (GO:0002710) | 3.67559433 |
| 49 | regulation of mast cell activation (GO:0033003) | 3.66501894 |
| 50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.62221555 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.59351841 |
| 52 | cellular response to type I interferon (GO:0071357) | 3.55558776 |
| 53 | type I interferon signaling pathway (GO:0060337) | 3.55558776 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.55291879 |
| 55 | response to type I interferon (GO:0034340) | 3.52796672 |
| 56 | positive regulation of mast cell degranulation (GO:0043306) | 3.50627108 |
| 57 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.50627108 |
| 58 | response to muramyl dipeptide (GO:0032495) | 3.48522845 |
| 59 | response to interleukin-15 (GO:0070672) | 3.45568857 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 3.43094910 |
| 61 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.40535281 |
| 62 | B cell mediated immunity (GO:0019724) | 3.40339865 |
| 63 | germinal center formation (GO:0002467) | 3.37101055 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.36745558 |
| 65 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.34933577 |
| 66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.33363793 |
| 67 | defense response to protozoan (GO:0042832) | 3.32551612 |
| 68 | regulation of tolerance induction (GO:0002643) | 3.26052763 |
| 69 | myeloid leukocyte mediated immunity (GO:0002444) | 3.26048859 |
| 70 | leukocyte degranulation (GO:0043299) | 3.24921987 |
| 71 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.22347755 |
| 72 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.19833944 |
| 73 | positive regulation of interferon-alpha production (GO:0032727) | 3.19692500 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 3.18979932 |
| 75 | negative regulation of interleukin-6 production (GO:0032715) | 3.14610237 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.14073634 |
| 77 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.13171843 |
| 78 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.12134168 |
| 79 | cellular response to interleukin-15 (GO:0071350) | 3.10631204 |
| 80 | regulation of interferon-alpha production (GO:0032647) | 3.10525983 |
| 81 | positive regulation of B cell differentiation (GO:0045579) | 3.05425128 |
| 82 | neutrophil chemotaxis (GO:0030593) | 3.04501692 |
| 83 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.04416361 |
| 84 | B cell receptor signaling pathway (GO:0050853) | 3.04090967 |
| 85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.02126329 |
| 86 | regulation of B cell differentiation (GO:0045577) | 3.01442864 |
| 87 | regulation of antigen processing and presentation (GO:0002577) | 3.00940570 |
| 88 | regulation of regulated secretory pathway (GO:1903305) | 3.00861401 |
| 89 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.00627800 |
| 90 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.00543832 |
| 91 | response to protozoan (GO:0001562) | 2.99933024 |
| 92 | positive regulation of antigen processing and presentation (GO:0002579) | 2.99093583 |
| 93 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98431590 |
| 94 | myeloid leukocyte activation (GO:0002274) | 2.97472360 |
| 95 | neutrophil migration (GO:1990266) | 2.96703434 |
| 96 | negative regulation of innate immune response (GO:0045824) | 2.96041681 |
| 97 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.92699436 |
| 98 | dendritic cell migration (GO:0036336) | 2.88880936 |
| 99 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.88405075 |
| 100 | negative regulation of phagocytosis (GO:0050765) | 2.87735602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.00547501 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.22614581 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.68338118 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.72697492 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.70695551 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.51202632 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.39495305 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.05166067 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.98397818 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.92740398 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88485208 |
| 12 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.81144013 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.77228529 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.71393284 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.65111660 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.58674110 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.54527687 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54024962 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51964516 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43615826 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.25403355 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.24790167 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.19716698 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19538121 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.19418726 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.17666538 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.16702770 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.15755260 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.11712694 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.09925649 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.05637213 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.95548769 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.95344590 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.93694894 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89060794 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.81243503 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74063145 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.73961017 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.70148356 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68220401 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67607017 |
| 42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.67432393 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67180792 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.62115114 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.57661857 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50198190 |
| 47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50157503 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48957235 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.47816341 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43731914 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42943284 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42938859 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.40559365 |
| 54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40315441 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37614094 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37534598 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35616526 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35051379 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33732794 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33330180 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33222774 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32995493 |
| 63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32884257 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32612138 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31589190 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28437123 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27844080 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27263940 |
| 69 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25546133 |
| 70 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24333202 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23959732 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23656402 |
| 73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23252950 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18327999 |
| 75 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18121901 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15008201 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13312939 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13285639 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10850240 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09689620 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08804818 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06628224 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04692030 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03355716 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98903587 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95917079 |
| 87 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95354629 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94961312 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91802197 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90040249 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88264552 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86932707 |
| 93 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84746046 |
| 94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82106876 |
| 95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.79686239 |
| 96 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79352364 |
| 97 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74930674 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74006840 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.73561711 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.72202353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.16897068 |
| 2 | MP0003436_decreased_susceptibility_to | 4.26899208 |
| 3 | MP0003303_peritoneal_inflammation | 4.22359536 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.80246607 |
| 5 | MP0002419_abnormal_innate_immunity | 3.35979485 |
| 6 | MP0009785_altered_susceptibility_to | 3.15013514 |
| 7 | MP0005671_abnormal_response_to | 3.05951176 |
| 8 | MP0005025_abnormal_response_to | 3.04810658 |
| 9 | MP0005387_immune_system_phenotype | 2.93470786 |
| 10 | MP0001790_abnormal_immune_system | 2.93470786 |
| 11 | MP0006082_CNS_inflammation | 2.92402344 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.91219214 |
| 13 | MP0001800_abnormal_humoral_immune | 2.84190704 |
| 14 | MP0000685_abnormal_immune_system | 2.78881982 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.69973212 |
| 16 | MP0002723_abnormal_immune_serum | 2.62995679 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.58141048 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.51110973 |
| 19 | MP0001819_abnormal_immune_cell | 2.49061340 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.34142611 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.27329843 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.14514806 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.01110154 |
| 24 | MP0002405_respiratory_system_inflammati | 1.99258703 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.96742362 |
| 26 | MP0009278_abnormal_bone_marrow | 1.96501153 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.86600023 |
| 28 | MP0000716_abnormal_immune_system | 1.80687967 |
| 29 | MP0009764_decreased_sensitivity_to | 1.80658097 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.75459002 |
| 31 | MP0002398_abnormal_bone_marrow | 1.75273847 |
| 32 | MP0003828_pulmonary_edema | 1.71013727 |
| 33 | MP0004947_skin_inflammation | 1.67014298 |
| 34 | MP0002277_abnormal_respiratory_mucosa | 1.63949021 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.62847158 |
| 36 | MP0002132_abnormal_respiratory_system | 1.62272350 |
| 37 | MP0004510_myositis | 1.58562955 |
| 38 | MP0008469_abnormal_protein_level | 1.58285025 |
| 39 | MP0008260_abnormal_autophagy | 1.56366971 |
| 40 | MP0003075_altered_response_to | 1.52811400 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.52434337 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.47494991 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.45124474 |
| 44 | MP0002722_abnormal_immune_system | 1.42416498 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.41825418 |
| 46 | MP0005310_abnormal_salivary_gland | 1.40826974 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.40139616 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.40139616 |
| 49 | MP0002429_abnormal_blood_cell | 1.39867737 |
| 50 | MP0003866_abnormal_defecation | 1.36494501 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.36458145 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.28113645 |
| 53 | MP0004883_abnormal_blood_vessel | 1.26315839 |
| 54 | MP0005451_abnormal_body_composition | 1.23974197 |
| 55 | MP0000858_altered_metastatic_potential | 1.20579689 |
| 56 | MP0000343_altered_response_to | 1.18026031 |
| 57 | MP0001851_eye_inflammation | 1.17046940 |
| 58 | MP0003690_abnormal_glial_cell | 1.14085836 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.13311369 |
| 60 | MP0008004_abnormal_stomach_pH | 1.12695593 |
| 61 | MP0005166_decreased_susceptibility_to | 1.11138577 |
| 62 | MP0005164_abnormal_response_to | 1.10016597 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.08860404 |
| 64 | MP0004381_abnormal_hair_follicle | 1.07836099 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.00558276 |
| 66 | MP0001853_heart_inflammation | 0.99390010 |
| 67 | MP0003448_altered_tumor_morphology | 0.92958701 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 0.92298860 |
| 69 | MP0005390_skeleton_phenotype | 0.91591387 |
| 70 | MP0009763_increased_sensitivity_to | 0.90540644 |
| 71 | MP0001663_abnormal_digestive_system | 0.89717798 |
| 72 | MP0000604_amyloidosis | 0.82981567 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 0.81512275 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 0.81078620 |
| 75 | MP0001986_abnormal_taste_sensitivity | 0.79242200 |
| 76 | MP0002166_altered_tumor_susceptibility | 0.77870031 |
| 77 | MP0003045_fibrosis | 0.76367677 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.74746982 |
| 79 | MP0000015_abnormal_ear_pigmentation | 0.72600787 |
| 80 | MP0009840_abnormal_foam_cell | 0.71741195 |
| 81 | MP0001873_stomach_inflammation | 0.71515553 |
| 82 | MP0000569_abnormal_digit_pigmentation | 0.69838425 |
| 83 | MP0002332_abnormal_exercise_endurance | 0.64881258 |
| 84 | MP0003795_abnormal_bone_structure | 0.64218827 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 0.63771021 |
| 86 | MP0002254_reproductive_system_inflammat | 0.62137153 |
| 87 | MP0000249_abnormal_blood_vessel | 0.59761936 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.59541552 |
| 89 | MP0000490_abnormal_crypts_of | 0.59526039 |
| 90 | MP0008874_decreased_physiological_sensi | 0.59202730 |
| 91 | MP0004130_abnormal_muscle_cell | 0.58847959 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.58118786 |
| 93 | MP0002933_joint_inflammation | 0.52628060 |
| 94 | MP0000920_abnormal_myelination | 0.52119853 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.51871996 |
| 96 | MP0002006_tumorigenesis | 0.51304035 |
| 97 | MP0005535_abnormal_body_temperature | 0.47917021 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.46315120 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.45867935 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.45558946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.65685497 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.22944824 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.19781462 |
| 4 | Myositis (HP:0100614) | 6.16717543 |
| 5 | Orchitis (HP:0100796) | 6.00556536 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.94407296 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.77954491 |
| 8 | Optic neuritis (HP:0100653) | 5.77954491 |
| 9 | Stomatitis (HP:0010280) | 5.49857185 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.18439685 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.92070949 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.29395196 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 4.24475139 |
| 14 | Obstructive lung disease (HP:0006536) | 4.24475139 |
| 15 | Keratoconjunctivitis sicca (HP:0001097) | 4.16092436 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.13305252 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 4.08892370 |
| 18 | Recurrent skin infections (HP:0001581) | 4.02657516 |
| 19 | Meningitis (HP:0001287) | 3.97451022 |
| 20 | Keratoconjunctivitis (HP:0001096) | 3.96547374 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.78642304 |
| 22 | Encephalitis (HP:0002383) | 3.76893142 |
| 23 | Hypochromic microcytic anemia (HP:0004840) | 3.71029123 |
| 24 | Vasculitis (HP:0002633) | 3.63620412 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.61062898 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.61062898 |
| 27 | Urticaria (HP:0001025) | 3.56834669 |
| 28 | Spontaneous hematomas (HP:0007420) | 3.42397480 |
| 29 | Gingivitis (HP:0000230) | 3.41479805 |
| 30 | Increased IgE level (HP:0003212) | 3.37892906 |
| 31 | Hemoptysis (HP:0002105) | 3.31078528 |
| 32 | Pulmonary infiltrates (HP:0002113) | 3.27113369 |
| 33 | Episodic fever (HP:0001954) | 3.25557409 |
| 34 | Chest pain (HP:0100749) | 3.19543937 |
| 35 | Amyloidosis (HP:0011034) | 3.18059028 |
| 36 | Prolonged bleeding time (HP:0003010) | 3.15892887 |
| 37 | Hypochromic anemia (HP:0001931) | 3.14667565 |
| 38 | Arterial thrombosis (HP:0004420) | 2.99276342 |
| 39 | Anorexia (HP:0002039) | 2.95366865 |
| 40 | Abnormality of glycolipid metabolism (HP:0010969) | 2.88026789 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.88026789 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.88026789 |
| 43 | Leukocytosis (HP:0001974) | 2.87817971 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.85077026 |
| 45 | Cellulitis (HP:0100658) | 2.80233462 |
| 46 | Pulmonary embolism (HP:0002204) | 2.79816107 |
| 47 | Gingival bleeding (HP:0000225) | 2.73682019 |
| 48 | Petechiae (HP:0000967) | 2.71831430 |
| 49 | Gangrene (HP:0100758) | 2.68761985 |
| 50 | Peritonitis (HP:0002586) | 2.65810971 |
| 51 | Epistaxis (HP:0000421) | 2.60136946 |
| 52 | T lymphocytopenia (HP:0005403) | 2.59806055 |
| 53 | Abnormality of the pleura (HP:0002103) | 2.56476378 |
| 54 | Recurrent viral infections (HP:0004429) | 2.54475845 |
| 55 | Abnormality of T cell number (HP:0011839) | 2.54337676 |
| 56 | Pustule (HP:0200039) | 2.53185011 |
| 57 | Increased IgM level (HP:0003496) | 2.51924137 |
| 58 | Inflammation of the large intestine (HP:0002037) | 2.47351742 |
| 59 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.38308188 |
| 60 | Osteomyelitis (HP:0002754) | 2.35991268 |
| 61 | Granulocytopenia (HP:0001913) | 2.35362692 |
| 62 | Gastrointestinal inflammation (HP:0004386) | 2.35333041 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.33117405 |
| 64 | Abnormality of T cells (HP:0002843) | 2.32440081 |
| 65 | Loss of speech (HP:0002371) | 2.32400745 |
| 66 | Microcytic anemia (HP:0001935) | 2.31318113 |
| 67 | Increased serum ferritin (HP:0003281) | 2.29035421 |
| 68 | Purpura (HP:0000979) | 2.28059046 |
| 69 | Sepsis (HP:0100806) | 2.26612868 |
| 70 | Vertigo (HP:0002321) | 2.26436083 |
| 71 | Keratitis (HP:0000491) | 2.25549398 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.20900535 |
| 73 | Abnormality of the endocardium (HP:0004306) | 2.19541094 |
| 74 | Polyneuropathy (HP:0001271) | 2.18147507 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.16352669 |
| 76 | Abnormality of the pericardium (HP:0001697) | 2.16342016 |
| 77 | Glomerulopathy (HP:0100820) | 2.16250318 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.13587080 |
| 79 | Lymphopenia (HP:0001888) | 2.10632022 |
| 80 | Acne (HP:0001061) | 2.09363425 |
| 81 | Hepatosplenomegaly (HP:0001433) | 2.08392738 |
| 82 | Vacuolated lymphocytes (HP:0001922) | 2.08138034 |
| 83 | Disinhibition (HP:0000734) | 2.06177368 |
| 84 | Abnormality of the peritoneum (HP:0002585) | 2.05071838 |
| 85 | Abnormality of T cell physiology (HP:0011840) | 2.04798486 |
| 86 | Premature loss of primary teeth (HP:0006323) | 2.03317905 |
| 87 | Eosinophilia (HP:0001880) | 2.02022362 |
| 88 | Autoimmune thrombocytopenia (HP:0001973) | 2.01290164 |
| 89 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.99156842 |
| 90 | Dysostosis multiplex (HP:0000943) | 1.98239325 |
| 91 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95233541 |
| 92 | Chronic otitis media (HP:0000389) | 1.94033001 |
| 93 | Colitis (HP:0002583) | 1.93196461 |
| 94 | Skin ulcer (HP:0200042) | 1.92147985 |
| 95 | Recurrent pneumonia (HP:0006532) | 1.89431897 |
| 96 | Cheilitis (HP:0100825) | 1.83779936 |
| 97 | Restrictive lung disease (HP:0002091) | 1.83555660 |
| 98 | Thrombophlebitis (HP:0004418) | 1.83550200 |
| 99 | Arthralgia (HP:0002829) | 1.81030050 |
| 100 | Skin rash (HP:0000988) | 1.80987646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.06821419 |
| 2 | MAP4K1 | 3.46151748 |
| 3 | BLK | 3.40145810 |
| 4 | IRAK4 | 3.31096532 |
| 5 | MAP2K3 | 2.94544322 |
| 6 | TYK2 | 2.92797533 |
| 7 | CSK | 2.83126249 |
| 8 | ERN1 | 2.63108967 |
| 9 | FES | 2.53097732 |
| 10 | TNK2 | 2.40185092 |
| 11 | ZAP70 | 2.13581054 |
| 12 | GRK6 | 2.06882636 |
| 13 | TAOK1 | 1.97207736 |
| 14 | FGR | 1.94409177 |
| 15 | TXK | 1.90340716 |
| 16 | MAP3K14 | 1.89176418 |
| 17 | PRPF4B | 1.85971260 |
| 18 | EPHB1 | 1.82413937 |
| 19 | JAK3 | 1.80466388 |
| 20 | BTK | 1.80419526 |
| 21 | MAP3K3 | 1.79614341 |
| 22 | HCK | 1.73488869 |
| 23 | SYK | 1.71780510 |
| 24 | MAP3K11 | 1.64198200 |
| 25 | IKBKE | 1.64017867 |
| 26 | TBK1 | 1.54982426 |
| 27 | LYN | 1.45713260 |
| 28 | JAK2 | 1.43799671 |
| 29 | MAP3K13 | 1.33244476 |
| 30 | TAOK3 | 1.31606435 |
| 31 | CSF1R | 1.29966969 |
| 32 | MAP3K1 | 1.29681213 |
| 33 | MATK | 1.28281286 |
| 34 | KIT | 1.26642257 |
| 35 | JAK1 | 1.23752001 |
| 36 | SIK3 | 1.19916105 |
| 37 | IRAK1 | 1.17314365 |
| 38 | IKBKB | 1.15577486 |
| 39 | LCK | 1.14588638 |
| 40 | MARK3 | 1.14507336 |
| 41 | YES1 | 1.11470746 |
| 42 | KSR2 | 1.07350266 |
| 43 | IRAK3 | 1.06206239 |
| 44 | BMPR2 | 1.05364046 |
| 45 | IRAK2 | 1.03835611 |
| 46 | ITK | 1.02204478 |
| 47 | TAOK2 | 0.99760011 |
| 48 | CDK19 | 0.94081431 |
| 49 | TEC | 0.93837826 |
| 50 | PDK1 | 0.88046665 |
| 51 | TGFBR2 | 0.87585180 |
| 52 | GRK7 | 0.85716752 |
| 53 | MARK2 | 0.83597312 |
| 54 | SIK2 | 0.83158451 |
| 55 | PRKD2 | 0.81680378 |
| 56 | STK10 | 0.80768036 |
| 57 | DAPK2 | 0.78398008 |
| 58 | MAP3K6 | 0.77494233 |
| 59 | PDPK1 | 0.77057387 |
| 60 | PTK6 | 0.74695141 |
| 61 | TESK2 | 0.72253808 |
| 62 | MAP2K4 | 0.66715373 |
| 63 | PTK2B | 0.65624240 |
| 64 | MAPK12 | 0.64571327 |
| 65 | CDC42BPA | 0.64022513 |
| 66 | FYN | 0.63249147 |
| 67 | PIK3CG | 0.62487861 |
| 68 | MAP3K5 | 0.60794788 |
| 69 | MAPK7 | 0.60266590 |
| 70 | STK11 | 0.57625761 |
| 71 | MAP3K7 | 0.56597505 |
| 72 | EPHA3 | 0.55170073 |
| 73 | PRKCQ | 0.53632681 |
| 74 | RPS6KL1 | 0.51208149 |
| 75 | RPS6KC1 | 0.51208149 |
| 76 | MAP2K6 | 0.48828775 |
| 77 | HIPK2 | 0.48358187 |
| 78 | SGK3 | 0.47867614 |
| 79 | RPS6KA6 | 0.46896779 |
| 80 | MAP3K2 | 0.45345592 |
| 81 | LRRK2 | 0.43702210 |
| 82 | DYRK1B | 0.43152177 |
| 83 | MOS | 0.43043950 |
| 84 | PIM1 | 0.41098189 |
| 85 | PRKG2 | 0.40431421 |
| 86 | SMG1 | 0.36344134 |
| 87 | RAF1 | 0.35887604 |
| 88 | CAMKK2 | 0.35690454 |
| 89 | PRKCZ | 0.33620408 |
| 90 | TRIB3 | 0.32658987 |
| 91 | MAPKAPK2 | 0.32618696 |
| 92 | FGFR3 | 0.32594273 |
| 93 | KSR1 | 0.32039391 |
| 94 | PRKCD | 0.31103341 |
| 95 | CHUK | 0.30891536 |
| 96 | ABL1 | 0.30413083 |
| 97 | RET | 0.29853985 |
| 98 | SGK2 | 0.29119267 |
| 99 | NLK | 0.29038915 |
| 100 | RPS6KA2 | 0.27726191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.23089304 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.17343807 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.12942469 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.59788773 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.57283666 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.34785099 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.34332047 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.18583522 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.13097058 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.08594454 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.07762408 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.06635679 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.02082207 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.98869567 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97827501 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.79823151 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.78607242 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75797826 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.71320081 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.69697877 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69174992 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.69065241 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.67792313 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.66941144 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.65759934 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59683695 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.59111873 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56247183 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.56119729 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51728863 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47080844 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.44899116 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43199041 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39951347 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39809090 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38241411 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35187372 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33494739 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32321092 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31772756 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.30152166 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 1.10890554 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.10865832 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.04636653 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.03170751 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03119532 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.02965770 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.02789498 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.02457994 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01961205 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.95509420 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87786431 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84900292 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83154961 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80363747 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80163146 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.78229898 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72994813 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72535767 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71577173 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68425342 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67169089 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.65128583 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64742571 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.63944012 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63912454 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62135245 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61976344 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61522032 |
| 70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58977784 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58299136 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58057127 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57035598 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56555875 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55516411 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54252541 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53782764 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52877745 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52195072 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48714373 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46005836 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45639394 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44810247 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44032444 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43407179 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41653632 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.41309816 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40786680 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40161968 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39814628 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39650742 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38294817 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35073259 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34903428 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34495770 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33479373 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31369855 |
| 98 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.29878076 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25327202 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25134925 |

